The number of diagnosed prevalent cases of SCA in the countries under study will increase by 10% over the 20-year forecast period, from 29,000 to 32,000.
Of the countries considered in this analysis, Japan has the highest diagnosed prevalence of SCA: 5.9 per 100,000.
The average age of all diagnosed prevalent cases of SCA in the countries under study is 61.
Fifty-two percent of all diagnosed prevalent cases of SCA in the countries under study are female.
Utsav Patel, M.P.H.,is an associate epidemiologist at Clarivate. Previously, he worked as a graduate research assistant at City University of New York, where he conducted multi-omics investigations into cancer study funded by the National Institutes of Health. He obtained his M.P.H. in epidemiology and biostatistics from City University of New York.
Alexandre Vo Dupuy, Pharm.D., M.Sc.
Alexandre Vo Dupuy, M.Sc., Pharm.D., is a principal epidemiologist at Clarivate. Previously, he worked in the fields of consulting and real-world evidence and at a major pharmaceutical company. He obtained his doctor of pharmacy from Descartes University in Paris and his master’s degree in pharmacoepidemiology from the University of Bordeaux.
